Kabsoo相关文献与解析，生知库 | 链接生命科学的每一步

Kim Ryul, Yu Jonghan, Lim Joonoh, Oh Brian Baek-Lok, Nam Seok Jin, Kim Seok Won, Lee Jeong Eon, Chae Byung Joo, Kim Ji-Yeon, Park Ga Eun, Kang Bong Joo, Paik Pill Sun, Bae Soo Yeon, Yoon Chang Ik, Lee Young Joo, Kim Dooreh, Shin Kabsoo, Lee Ji Eun, Kang Jun, Lee Ahwon, Connolly-Strong Erin, Lee Sangmoon, Lee Bo Rahm, Lee Yuna, Yi Ki Jong, Kwon Young Oh, Chun In Hwan, Park Junggil, Kim Jihye, Choi Chahyun, Shin Jong Yeon, Lee Hyungjung, Kim Minji, Park Hansol, Jeong Ilecheon, Yi Boram, Lee Won-Chul, Lee Jeong Seok, Park Woo Chan, Kim Sung Hun, Choi Yoon-La, Lee Jeongmin, Ju Young Seok, Park Yeon Hee

肿瘤

肿瘤免疫

乳腺癌

发表日期：2026

文献求助收藏

Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (-) metastatic breast cancer patients in Korea (KCSG BR21-15)

韩国 HR (+)、HER2 (-) 转移性乳腺癌患者使用帕博西尼治疗的全国真实世界实践模式和临床数据 (KCSG BR21-15)

期刊:Breast

影响因子:7.9

doi:10.1016/j.breast.2025.104500

Lee, Jieun; Lee, Dae-Won; Kim, Min Hwan; Kim, Jee Hung; Kim, Ju Won; Byun, Jae-Ho; Lee, Kyoung Eun; Kang, Myoung Joo; Koh, Su-Jin; Hong, Soojung; Won, Hye Sung; Kim, Han Jo; Park, In Hae; Shin, Seong Hoon; Baek, Sun Kyung; Kim, Seul-Gi; Koh, Sung Ae; Jung, Joo Young; Kim, Ji-Yeon; Kim, Gun Min; Shin, Kabsoo; Woo, In Sook; Kim, Hyun Seon; Im, Seock-Ah; Park, Yeon Hee

Clinical and Molecular Characteristics of KRAS Codon-Specific Mutations in Advanced Pancreatic Ductal Adenocarcinoma with Prognostic and Therapeutic Implications

晚期胰腺导管腺癌中KRAS密码子特异性突变的临床和分子特征及其预后和治疗意义

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms262210908

Cho, Dongwoo; Shin, Kabsoo; Hong, Tae Ho; Lee, Sung Hak; Kim, Younghoon; Kim, In-Ho; Hong, Sook-Hee; Lee, MyungAh; Park, Se Jun

Dynamic Integrative Immune Profiling Reveals Early Biomarkers of Response and Prognosis in Advanced Gastric Cancer Treated with Nivolumab Plus Chemotherapy.

动态整合免疫分析揭示了接受纳武利尤单抗联合化疗治疗的晚期胃癌患者的早期反应和预后生物标志物。

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers17193131

Kim Hyunho, Shin Kabsoo, Park Se Jun, Lee Myung Ah, Park Juyeon, Kim Okran, Kang Nahyeon, Kim In-Ho

Real-world outcomes of fluorouracil-based second-line therapy in patients with advanced biliary tract cancer refractory to gemcitabine and cisplatin-based treatment

氟尿嘧啶类二线治疗对吉西他滨和顺铂类药物耐药的晚期胆道癌患者的真实世界疗效

期刊:Therapeutic Advances in Medical Oncology

影响因子:4.2

doi:10.1177/17588359251335879

Park, Se Jun; Shin, Kabsoo; Kim, Hyunho; Park, Hyung Soon; Hong, Tae Ho; Kim, In-Ho; Lee, MyungAh

Exploring the efficacy of fluorouracil and platinum based chemotherapy in advanced hepatocellular carcinoma to bridge the treatment gap in resource limited settings

探索氟尿嘧啶和铂类化疗在晚期肝细胞癌治疗中的疗效，以弥合资源匮乏地区治疗方面的差距

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-86523-9

Park, Se Jun; Shin, Kabsoo; Kim, In-Ho; Lee, MyungAh; Hong, Tae Ho; Kim, Hyunho

Real-World Comparison of Trifluridine-Tipiracil with or Without Bevacizumab in Patients with Refractory Metastatic Colorectal Cancer

真实世界中三氟尿苷-替吡嘧啶联合或不联合贝伐珠单抗治疗难治性转移性结直肠癌患者的疗效比较

期刊:Biomedicines

影响因子:3.9

doi:10.3390/biomedicines13040976

Kim, Hyunho; Shin, Kabsoo; An, Ho Jung; Kim, In-Ho; Bae, Jung Hoon; Lee, Yoon Suk; Lee, In Kyu; Lee, MyungAh; Park, Se Jun

Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)

一项随机 II 期试验，旨在评估阿特珠单抗联合卡培他滨辅助治疗与卡培他滨单药治疗在接受新辅助化疗后仍有残留浸润性癌的三阴性乳腺癌中的疗效和安全性（MIRINAE 试验，KCSG-BR18-21）。

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-025-14673-0

Lee, Jieun; Ahn, Hee Kyung; Lee, Kyung-Hun; Jung, Kyung Hae; Park, Yeon Hee; Sim, Sung Hoon; Kim, Min Hwan; Kim, Jee Hyun; Kim, Jee Hung; Lee, Kyoung Eun; Park, Kyong Hwa; Bae, Jihong; Lee, Moon Hee; Lim, Seungtaek; Kim, Han Jo; Lee, Dae-Won; Jeong, Jae Ho; Kim, Ji-Yeon; Ahn, Jin Seok; Lee, Keun Seok; Sohn, Joohyuk; Suh, Koung Jin; Cha, Yoon Jin; Shin, Kabsoo; Kim, Sung-Bae; Chae, Heejung; Kim, Gun Min; Im, Seock-Ah; Park, In Hae

Liposomal irinotecan with fluorouracil and leucovorin as salvage treatment for advanced biliary tract cancer refractory to gemcitabine and cisplatin

脂质体伊立替康联合氟尿嘧啶和亚叶酸钙作为吉西他滨和顺铂耐药晚期胆道癌的挽救治疗

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2025.1638606

Kim, Hyunho; Shin, Kabsoo; Park, Hyung Soon; Hong, Tae Ho; Kim, Younghoon; Lee, Sung Hak; Kim, In-Ho; Lee, MyungAh; Park, Se Jun

Prognostic impact of endocrine therapy and BDNF-TrkB axis in breast cancer brain metastases.

内分泌治疗和 BDNF-TrkB 轴对乳腺癌脑转移预后的影响。

期刊:Journal of Neuro-Oncology

影响因子:3.1

doi:10.1007/s11060-025-05393-3

Kim Joori, Shin Kabsoo, Lee Ahwon, Lee Jieun

Whole-genome landscapes of 1,364 breast cancers.

1364 例乳腺癌的全基因组图谱。

Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (-) metastatic breast cancer patients in Korea (KCSG BR21-15)

韩国 HR (+)、HER2 (-) 转移性乳腺癌患者使用帕博西尼治疗的全国真实世界实践模式和临床数据 (KCSG BR21-15)

Clinical and Molecular Characteristics of KRAS Codon-Specific Mutations in Advanced Pancreatic Ductal Adenocarcinoma with Prognostic and Therapeutic Implications

晚期胰腺导管腺癌中KRAS密码子特异性突变的临床和分子特征及其预后和治疗意义

Dynamic Integrative Immune Profiling Reveals Early Biomarkers of Response and Prognosis in Advanced Gastric Cancer Treated with Nivolumab Plus Chemotherapy.

动态整合免疫分析揭示了接受纳武利尤单抗联合化疗治疗的晚期胃癌患者的早期反应和预后生物标志物。

Real-world outcomes of fluorouracil-based second-line therapy in patients with advanced biliary tract cancer refractory to gemcitabine and cisplatin-based treatment

氟尿嘧啶类二线治疗对吉西他滨和顺铂类药物耐药的晚期胆道癌患者的真实世界疗效

Exploring the efficacy of fluorouracil and platinum based chemotherapy in advanced hepatocellular carcinoma to bridge the treatment gap in resource limited settings

探索氟尿嘧啶和铂类化疗在晚期肝细胞癌治疗中的疗效，以弥合资源匮乏地区治疗方面的差距

Real-World Comparison of Trifluridine-Tipiracil with or Without Bevacizumab in Patients with Refractory Metastatic Colorectal Cancer

真实世界中三氟尿苷-替吡嘧啶联合或不联合贝伐珠单抗治疗难治性转移性结直肠癌患者的疗效比较

Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)

一项随机 II 期试验，旨在评估阿特珠单抗联合卡培他滨辅助治疗与卡培他滨单药治疗在接受新辅助化疗后仍有残留浸润性癌的三阴性乳腺癌中的疗效和安全性（MIRINAE 试验，KCSG-BR18-21）。

Liposomal irinotecan with fluorouracil and leucovorin as salvage treatment for advanced biliary tract cancer refractory to gemcitabine and cisplatin

脂质体伊立替康联合氟尿嘧啶和亚叶酸钙作为吉西他滨和顺铂耐药晚期胆道癌的挽救治疗

Prognostic impact of endocrine therapy and BDNF-TrkB axis in breast cancer brain metastases.

内分泌治疗和 BDNF-TrkB 轴对乳腺癌脑转移预后的影响。